Aeglea BioTherapeutics, Inc.

Q1 2021 13F Holders

Symbol
AGLE
CUSIP
00773J103
Type
Equity
Class
COM
Num filings
87
Total reported value, excl. options
$329 M
Manager Report Date Value ($000) Shares Option Type